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ABSTRACT
Objectives: The aims of this study were: (1) to identify which measurement instruments are used
in practice to assess the quality of life or well-being of individuals with and without (sub)fertility;
(2) to describe the design and outcomes of studies comparing quality of life or well-being of indi-
viduals with and without fertility problems; and (3) to determine which of the outcomes of the
identified studies could be used in cost-utility studies.
Methods: A systematic literature review was performed of studies published before July 2018,
using multiple databases. Included studies investigated (health-related) quality of life or well-being
of individuals with fertility problems. The applied instruments were assessed, as were the out-
comes and suitability for use in cost-utility studies.
Results: Twenty-six studies met the inclusion criteria. Twelve distinct instruments of measurement
were applied: two generic quality-of-life instruments, five generic well-being instruments and five
disease-specific instruments. Most studies found negative associations in one or more domains
assessing fertility problems and quality of life or well-being. However, two studies found the
opposite. None of the studies reported outcomes relevant for cost-utility studies.
Conclusion: Quality of life and well-being related to having fertility problems are regularly studied.
However, the reported information is not suitable for use in cost-utility studies. There is a clear
need for studies investigating the impact of fertility problems on quality of life in a way that out-
comes can be compared across studies and disease areas.
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Introduction
Up to 15% of reproductive-aged couples worldwide experi-
ence infertility [1]. In absolute numbers, 48.5 million cou-
ples are unable to fulfil their desire for a child (defined as
not having been able to conceive over a period of 5 years).
Of these, 19.2 million couples do not succeed in having a
first child and 29.3 million do not succeed in having a
second child [2]. About half of couples with infertility seek
medical help [3]. Fertility problems affect individuals in
high-income countries, as well as those in middle- and
low-income countries [2].
A study among the general Dutch population showed
that as many as 91% of those questioned considered hav-
ing mild fertility problems to be an unacceptable health
condition for women aged 30, and 93% felt that infertility
was unacceptable [4]. In other words, fertility seems an
important aspect of a normal healthy life. Be that as it
may, not being fertile, or being less fertile, may not result
in directly visible health problems. Fertility care may there-
fore sometimes be seen as unnecessary or of low priority.
In practice, in many countries this has resulted in policies
limiting access to fertility care in health insurance schemes
or in national health service systems. In the Netherlands,
couples currently get a maximum of three in vitro fertilisa-
tion (IVF) or intra-cytoplasmic sperm injection attempts
reimbursed through the basic benefits package of the man-
datory health insurance system. In Austria, 70% of treat-
ment and drug costs are reimbursed under certain
circumstances, while in the USA a large proportion of
women pay for their own treatment [5]. These limitations
in access to fertility-related care may contribute to the bur-
den of disease of women with fertility problems.
Although, obviously, the most important outcome of fer-
tility treatment may be considered the birth of a baby, this
outcome may not be the primary outcome considered in
policy-makers’ reimbursement decisions. In many countries,
cost-effectiveness outcomes play an important role in these
decisions. In other words, does a treatment (e.g. IVF) offer
value for money? Effectiveness in cost-effectiveness studies
is preferentially expressed in costs per quality-adjusted life
year (QALY). Cost-effectiveness studies expressing out-
comes in QALYs are commonly referred to as cost-utility
studies. The QALY is a composite measure of length of life
and quality of life of the individual. However, most health
economic studies with regard to fertility treatment examine
the costs of fertility treatment per live birth, rather than
the costs per QALY gained. The difficulty for policy-makers
is that costs per live birth cannot be compared with cost-
effectiveness outcomes of other medical interventions
treating other diseases. Consequently, it is not possible to
determine whether fertility treatments offer value for
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money compared with treatments for other diseases. In
order to be able to conduct cost-utility studies it is neces-
sary to have insights into the effects of subfertility and
infertility on quality of life.
The effect of fertility problems on the quality of life of
individuals has often been studied. Outcomes show that
infertility can cause tremendous psychological distress in
women and men. Disease severity may sometimes be as
profound as that of life-threatening diseases such as cancer
and heart disease [6]. Still, such evidence may not always
reach policy-makers, or be adequately included in reimburse-
ment decisions, since the quality-of-life studies were not
designed to feed cost-utility studies. Most available evidence
is collected in studies within social sciences covering a single
domain of health or well-being rather than general quality
of life. In order for evidence to be able to be included in
cost-utility studies, quality of life needs to be measured and
valued in such a way that the outcomes are comparable
across diseases. Commonly, this implies using preference-
based generic quality-of-life or well-being instruments.
The extent to which evidence is available regarding the
effects of fertility problems on quality of life suitable for
use in cost-utility studies is unclear. To gain insights into
the impact of infertility on quality of life, it is especially
interesting to examine studies comparing the quality of life
or well-being of women with fertility problems with that of
people without fertility problems.
The aims of this study were: (1) to identify which meas-
urement instruments are used in practice to assess the
quality of life or well-being of individuals with and without
(sub)fertility; (2) to describe the design and outcomes of
studies comparing quality of life or well-being of individu-
als with and without fertility problems; and (3) to deter-
mine which of the outcomes of the identified studies could
be used in cost-utility studies.
In order to meet these objectives an extensive system-
atic review was conducted using multiple databases.
Methods
The systematic review was set up to identify a wide scope
of scientific studies investigating either disease-specific or
generic quality of life and/or well-being of individuals with
fertility problems now or in the past, with or without (ever)
receiving treatment, with or without children.
The review included the following databases: Medline
(OvidSP), Web of Science, PsycINFO (OvidSP), Embase,
Cochrane, PubMed and Google Scholar. The searches were
conducted to include all studies published before 9 July
2018. Words included in the search strategy were related
to: (1) fertility (such as ‘fertility’, ‘subfertility’ and ‘infertility’);
(2) quality-of-life aspects (including ‘well-being’, ‘quality of
life’ and ‘distress’); and (3) measurement instruments
(including ‘questionnaire’, ‘scale’ and ‘score’). Different
search strategies were explored to determine the most eli-
gible one, thus including the most relevant studies. The
specific search queries may be found in the appendix.
Inclusion and exclusion criteria
The inclusion and exclusion criteria were as follows: (1)
studies had to specifically assess generic or disease-specific
quality of life or well-being of humans with (past) infertil-
ity/subfertility; (2) studies had to be of a quantitative
nature (e.g. studies applying open interviews were
excluded); (3) studies had to be original scientific research
(i.e. comments, editorials and reviews were excluded); (4)
studies were excluded if they were primarily aimed at the
evaluation of a specific fertility-related treatment; (5) stud-
ies were excluded when they focussed on fertility-related
problems or causes of infertility, when they studied the
relationship between quality of life or well-being and fac-
tors other than fertility, or when they investigated an indir-
ect effect of fertility on quality of life or well-being (e.g. the
role of coping styles in the effect of infertility on quality of
life); (6) studies were excluded when they focused on many
conditions of which subfertility or infertility was one; (7)
studies had to compare quality of life or well-being of indi-
viduals with and without fertility problems; and (8) instru-
ment development studies were excluded.
Identification of published studies and instruments
To identify the relevant published papers from the initial
search, the following procedure was undertaken. First, titles
and abstracts were examined and independently coded by
two researchers (KH and MK) as irrelevant, likely to be rele-
vant, or unclear. Differences were discussed until consensus
was reached. In case of doubt, studies were included in the
full-text investigation. Studies that were coded as irrelevant
received an additional code to describe which of the inclu-
sion criteria were not met or which exclusion criteria applied.
After the title and abstract search, full-text papers were
examined to determine whether all inclusion criteria were
indeed met and the exclusion criteria did not apply. Full-
text examinations were conducted in close collaboration
between KH and MK.
After relevant studies had been identified, it was
assessed what the studies aimed to measure specifically
and what type of instrument was used to measure quality
of life or well-being: generic, disease or domain specific.
Generic instruments are designed to measure quality of life
over the complete spectrum of diseases in various popula-
tions and can be used to compare changes across different
patient groups. Disease-specific instruments are designed
to measure the most relevant domains of quality of life
specific to a particular disease, while domain-specific instru-
ments focus on a single domain of health (e.g. social well-
being). After identifying the instruments, the content of the
applied instruments was examined and summarised.
An overview table was constructed summarising the
main characteristics of the studies comparing quality of life
or well-being of people with and without fertility problems,
such as the study aim, the sample size, the instruments
used and the main outcomes. Finally, it was investigated
whether the applied instruments and the presented out-
comes in the studies were suitable for use in cost-util-
ity studies.
Compliance with ethical standards
As this article does not contain any studies with human
participants or animals performed by any of the authors,
no ethics approval was required.
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Results
Review process
As shown in Figure 1, the initial database searches identi-
fied 11,065 potentially relevant papers, of which 4695
duplicate studies were detected and excluded by means of
EndNote X7 (https://endnote.com). A further 14 duplicates
were detected and manually removed. Title and abstract
searches resulted in the exclusion of 6305 studies: 1426
were not primarily aimed at fertility, 1083 did not consider
quality of life or well-being as a main theme, 333 explored
non-human subjects, 75 were qualitative studies, 36 did
not report original scientific research, 1499 were about
treatment of fertility and fertility-related problems, 1106
investigated causes of infertility, 587 were about the rela-
tionship between quality of life or well-being and other
factors than fertility, 24 studied an indirect effect of fertility
on quality of life or well-being, 87 were reviews of previous
literature, 21 did not compare quality of life/well-being of
individuals with and without fertility problems, and 28
aimed to validate rather than apply instruments. The initial
similarity percentage between the coding of the research-
ers in the title and abstract examination was high (91.8%).
A total of 51 studies were intended to be included in
the full-text examinations. However, we were not able to
obtain the full-text paper of three studies; 22 studies were
excluded based on the full-text examination. This left a
total of 26 studies included in the analyses.
A short description of the design of the studies, an over-
view of the quality-of-life and/or well-being instruments
used and a summary of the studies’ outcomes are pre-
sented in Table 1. In most countries only one or two
studies were conducted, with the exception of Iran (six
studies) [8–10,13,23,27], Germany (three studies) [22,28,31]
and Turkey (three studies) [25,26,29]. Most studies had
similar aims and objectives (to compare quality of life/well-
being of individuals with fertility problems with quality of
life/well-being of individuals without fertility problems).
However, study populations differed. For instance, some
studies investigated quality of life of individuals during IVF
treatment and some of individuals after IVF treatment.
Some only studied women’s quality of life, while others
investigated quality of life in couples. Diverse quality-of-life
and well-being instruments were used.
Quality-of-life and well-being instruments
We identified 12 instruments used in the 26 studies, of
which three were generic instruments measuring quality of
life, five were generic instrument measuring well-being and
four were disease-specific instruments. A short description
of the applied instruments is provided in Table 2. The
study outcomes are discussed below. When a difference in
outcomes is described as significantly different, it is statis-
tically different according to the outcomes reported in the
specific study. Note that the distinction between quality-of-
life instruments and well-being instruments was not always
evident. We categorised the instruments based on labelling
of the instrument in the instruments’ modes of instruction.
Generic quality-of-life instruments and their outcomes
Sixteen of the 26 identified studies applied a generic health
status or quality-of-life instrument. Three different (types of)
generic instruments were used: the Short Form 36 (SF-36),
two versions of World Health Organization (WHO) quality-of-
life measures – the abbreviated version, WHOQOL-BREF, and
the WHOQOL-100 – and one self-constructed rating scale.
The SF-36 was used in nine of the included empirical
studies [8–10,12–16,29]. De Pascalis et al. [12] found that
couples who underwent successful assisted reproductive
technology (ART) reported lower quality of life in the SF-36
physical summary score. Ashraf et al. [10] reported signifi-
cantly worse scores in quality of life of infertile or subfertile
women compared with fertile women in the domains of
physical functioning, role limitations due to physical prob-
lems, general health, vitality, social functioning, role limita-
tions due to emotional problems and mental health.
Ahmadi et al. [8] reported that during pregnancy, women
who conceived naturally had better physical functioning
and less role limitation due to physical problems, less bod-
ily pain and better social functioning, while women who
conceived by ART reported better general health, vitality,
role limitation due to emotional problems and mental
health. After childbirth, women who had conceived by ART
scored better compared with the natural conception group
on all but one dimension. Drosdzol and Skrzypulec [14]
showed significantly worse scores on the SF-36 among
infertile women compared with fertile controls in five out
of nine domains, while the other indices were slightly but
insignificantly better. Infertile males were found to have no
significantly different values compared with fertile controls,
although vitality was slightly decreased. El Kissi et al. [15]
found a lower summary score in the mental dimension of
Records identified through database search
(n=11,065)
Excluded (n=6305):
Fertility not main theme (n=1426)
Quality of life/well-being not main 
theme (n=1083)
Non-human study (n=333)
Qualitative research (n=75)
Not original scientific research 
(n=36)
Treatment of fertility and related 
problems (n=1499)
Explanatory factors of fertility 
(n=1106)
Relationship with quality of 
life/well-being (n=587)
Indirect effect (n=24)
Review (n=87)
No comparison (n=21)
Validation of instruments (n=28)
Full-text articles assessed for 
eligibility
(n=48)
Studies included in the review
(n=26)
Duplicates removed
(n=4709)
Titles and abstracts screened
(n=6356)
Unable to obtain full text
(n=3)
Full-text articles excluded 
(n=22):
Quality of life/well-being not
main theme (n=8)
No original scientific research 
(n=2)
Treatment of fertility and related 
problems (n=4)
Explanatory factors of fertility 
(n=8)
Figure 1. Flow diagram.
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the SF-36 among infertile men compared with controls.
Infertile women compared with controls scored worse on
both summary scores. Amiri et al. [9] found that the total
quality-of-life score was not significantly different between
fertile and infertile women. Direkvand-Moghadam et al. [13]
found that infertile women scored worse in the domains of
physical function, role limitations due to physical problems,
general health, vitality, social functioning, role limitations
due to emotional problems and mental health. Graham [16]
found that childless women experienced significantly better
scores on the mental and physical component summary
measures compared with mothers. Sezgin et al. [29] found
that infertile women reported poorer quality of life com-
pared with fertile control women.
The WHOQOL-BREF was used in five studies
[7,23,25–27]. Masoumi et al. [23] found that fertile couples
had significantly higher quality of life compared with infer-
tile couples. Sani and Tamannaeifar [27] found the quality
of life of infertile women to be lower than that of fertile
women. Onat and Beji [25] reported a significantly higher
quality-of-life score among the infertile group compared
with the fertile group in all subdomains of the WHOQOL-
BREF. By contrast, Pinar and Zeyneloglu [26] reported
scores in all subdomains of quality of life to be significantly
lower in the infertile group. Aduloju et al. [7] found that
quality of life was significantly lower among infertile
women compared with fertile women. The WHOQOL-100
was used in one study, by Xiaoli et al. [32], who concluded
that infertile women had significantly lower overall quality
of life compared with fertile women.
Klemetti et al. [21] measured quality of life on a single-item
scale from 0 to 10 and concluded that quality of life was sig-
nificantly lower among infertile childless men compared with
fertile men, but no difference was found among women.
Generic well-being instruments and their outcomes
Six of the 26 identified studies applied five different well-
being instruments: the Psychological General Well-Being
Table 2. Applied quality-of-life and well-being instruments.
Instrument Description
Availability of
preference-based
utility weights Study
Generic QoL instruments
SF-36 The SF-36 is a generic instrument used to measure health status in
8 dimensions: physical function, role limitations due to physical
problems, bodily pain, general health, vitality, social functioning,
role limitations due to emotional problems and mental health;
these domains can be used to compose the Physical Component
Summary and the Mental Component Summary [33]
Yes (convert to SF-6D) Ahmadi et al. [8]
Amiri et al. [9]
Ashraf et al. [10]
De Pascalis et al. [12]
Direkvand-Moghadam
et al. [13]
Drosdzol and
Skrzypulec [14]
El Kissi et al. [15]
Graham [16]
Sezgin et al. [29]
WHOQOL-100 The WHOQOL-100 is a QoL instrument developed by the WHO; it
contains 100 items scored on a 5 point Likert scale [32]
No Xiaoli et al. [32]
WHOQOL-BREF The WHOQOL-BREF is a QoL instrument developed by the WHO; it
is an abbreviated version of the WHOQOL-100 and contains 27
items divided over four subdomains: physical, emotional, environ-
mental and social [26]
No Aduloju et al. [7]
Masoumi et al. [23]
Onat and Beji [25]
Pinar and Zeyneloglu [26]
Sani et al. [27]
Generic well-being
instruments
QWB The QWB is a preference-based instrument designed to classify
health status from which health-state values can be calculated;
outcomes are presented on a scale between 0 and 1, where higher
values indicate better health-related QoL [24]
Yes Monga et al. [24]
PGWB The PGWB is a generic instrument used to measure psychological
general well-being, indicating subjective well-being and distress in
six domains: anxiety, depressed mood, positive well-being, self-con-
trol, general health, and vitality; a higher score indicates better
well-being [19]
No Johansson et al. [19]
Johansson et al. [20]
SPWB-SF The SPWB-SF is used to assess overall psychological well-being and
has subscales on well-being of autonomy, environmental mastery,
personal growth, positive relations with others, purpose in life and
self-acceptance [18]
No Jeffries and Konnert [18]
Von Zerssen
symptom checklist
The Von Zerssen symptom checklist is applied to determine sub-
jective well-being, consisting of 24 items including somatic, general
and psychological symptoms; the total score indicates the extent
of subjective impairment [22]
No Kowalcek et al. [22]
Disease-specific QoL
and well-being
instruments
FertiQoL FertiQoL is a fertility-specific self-report questionnaire designed to
assess QoL of infertile individuals [34]
No Valsangkar et al. [30]
TLMK The TLMK is a fertility-specific instrument originally used to assess
QoL in men with a desire for a child; it consists of items covering
four areas: desire for a child and associated stress, gender identity,
marital relationship and psychological well-being [35]
No Schanz et al. [28]
QLQ-C30 The QLQ-C30 is designed to collect information on function, global
health, QoL and symptoms in cancer patients; a higher global score
indicates better QoL [17]
Yes Hassanin et al. [17]
QoL: quality of life.
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Index (PGWB), the Scales of Psychological Well-Being–Short
Form (SPWB-SF), the Von Zerssen symptom checklist, a self-
constructed rating scale on global well-being and the
Quality of Well-Being Scale (QWB). A description of the
instruments is provided in Table 2.
The PGWB was applied in two separate studies [19,20].
Johansson et al. [20] found that total PGWB scores and
domain scores, except anxiety, were worse among men
with unsuccessful IVF than among men with successful IVF.
Additionally, compared with controls, men with unsuccess-
ful IVF reported worse scores in the domains of depression
and positive well-being. Women who had undergone
unsuccessful IVF scored worse on depression compared
with a control group. However, no difference in total PGWB
scores was found when comparing successful IVF treat-
ments in men or women with a control group. Johansson
et al. [19] found that compared with control groups, men
with unsuccessful IVF scored worse in the PGWB domains
of depression and positive well-being, men with successful
IVF had better vitality, and women with unsuccessful IVF
had significantly worse well-being scores in anxiety
and depression.
The SPWB-SF was used in one cross-sectional study by
Jeffries and Konnert [18] which reported no significant dif-
ferences in overall psychological well-being between invol-
untarily childless women, voluntarily childless women
and mothers.
Kowalcek et al. [22] applied the generic Von Zerssen
symptom checklist to investigate the well-being of infertile
couples. These authors found no notable difference
between the symptom scores of infertile couples and the
applied reference data of healthy comparators.
In a study by Callan [11] a self-constructed rating scale
was used to measure global well-being. Well-being was
assessed by posing a question on life satisfaction on a 1–9
scale, where 1 indicated being not very satisfied and 9 very
satisfied. Comparing mothers, infertile women and volun-
tarily childless women, infertile women were less satisfied
with their life compared with voluntarily childless women.
The QWB was used in one study. Monga et al. [24]
found that women in couples seeking infertility treatment
showed lower health-related quality of life compared with
women in couples seeking elective sterilisation.
Additionally, no difference was found in men in the
same couples.
Disease-specific quality-of-life and well-being
instruments and their outcomes
Four of the 26 studies included in our review applied dis-
ease-specific instruments. Four different instruments were
applied: the Fertility Quality-of-Life Questionnaire
(FertiQoL), the T€ubinger Lebensqualit€atsfragebogen f€ur
M€anner mit Kinderwunsch (TLMK), the Quality-of-Life
Questionnaire C30 (QLQ-C30) and one self-constructed rat-
ing scale.
Valsangkar et al. [30] applied the FertiQoL instrument
and found that infertile women had a lower fertility-related
quality of life compared with reference data.
Applying the TLMK, Schanz et al. [28] found that the
quality-of-life scores over 5 years of involuntarily childless
men had improved in the domains of desire for a child and
gender identity, indicating that the negative impact of
these domains had decreased. However, no differences in
quality of life were found among those who had become
fathers and those who remained childless.
The QLQ-C30 was used in a case–control study by
Hassanin et al. [17], who reported that infertile women had
a significantly lower quality of life compared with fer-
tile women.
Wischmann et al. [31] applied a generic rating system
comparing subjective change in quality of life on a single
scale of 1–5 (1 indicating being much worse after termin-
ation of infertility treatment and 5 being much better).
They found that childless men and women and parents
reported increased quality of life after termination of infer-
tility treatment, but this increase was not significantly dif-
ferent between childless partners and parents.
Quality-of-life and well-being outcomes
The majority of the included studies reported decreased
quality of life or well-being in one or more domains due to
infertility/subfertility. Sixteen out of the 26 studies showed
evidence of significantly deprived health status in men,
women and couples in one or more domains
[7,10–15,17,21,23,24,26,27,29,30,32]. Two studies found the
opposite for either women or couples [16,25]. Eight studies
found no overall evident relationship between infertility/
subfertility and quality of life or well-being
[8,9,18–20,22,28,31].
Suitability for use in cost-utility studies
Preference-based utility weights were available for three of
the 12 applied instruments in the studies included in this
review. Such utility weights are important since these can
be used to construct QALYs to allow for comparison of out-
comes across diseases. The three instruments for which
preference-based utility weights were available (and there-
fore suitable for use in cost-utility studies) are the SF-36,
the QWB and the QLQ-C30. As shown in Table 2, these
instruments were applied in 11 studies. This means that in
those studies it would have been possible to report utilities
that could be applied in cost-utility studies. However, none
of the studies reported outcomes in utilities.
Discussion
The impact of having fertility problems on quality of life
and well-being of individuals is regularly studied. Our study
reviewed the available evidence regarding the impact of
having fertility problems on quality of life and well-being.
Findings and interpretation
The outcomes of this systematic review indicated that the
relationship between fertility and quality of life is not
always clear. Although in most studies people with fertility
problems scored lower in one or more domains of quality
of life/well-being, not all did. Moreover, the association
between having fertility problems and different domains of
quality of life was not consistent between studies. There
can be various reasons for these differences. For instance,
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the 26 studies were conducted in 15 different countries;
cultural differences in these countries, such as social
acceptability of infertility, are likely to have influenced the
association between fertility problems and quality of life.
Moreover, the differences in reported outcomes may be
related to other aspects of the study design, such as the
sample size and, obviously, the applied instruments. The 26
studies reported a total of 12 distinct instruments, making
comparisons between studies difficult. In addition, the
study population of interest differed between studies. Of
course, having insight into the effect of fertility problems
on quality of life in different subgroups is in
itself important.
Almost half of the studies applied instruments that
enable the outcomes to be presented in terms of utilities.
Remarkably, however, none of the studies reported quality-
of-life outcomes expressed in utilities (which is necessary
to be able to include outcomes in cost-utility studies). This
implies that in order to be able to properly include the
available quality-of-life evidence related to (in)fertility in
comparative health economic analyses it is necessary to
reanalyse the available data to calculate the outcomes in
terms of utilities. This could also allow interesting compari-
sons of outcomes between the available studies.
Limitations and strengths of the study
A potential limitation of this review deserves attention.
Although the search strategy was quite extensive, we
might have missed some relevant quality-of-life evidence
as a result of methodological choices made, such as
excluding multi-disease studies and studies primarily aimed
at the evaluation of a specific treatment.
Despite this limitation, some findings are important.
Although outcomes were not consistent, evidence seems
to indicate that there is a negative association between
having fertility problems and quality of life/well-being.
Unanswered questions and future research
How the impact of fertility problems on quality of life
relates to other health problems is far from clear.
Therefore, it is necessary to better quantify the impact of
fertility problems on quality of life and well-being to deter-
mine the relative impact compared with that of having
other health problems. It is advised that future studies
(additionally) include generic quality-of-life/well-being
instruments and subsequently report the outcomes in
terms of comparable measures. Suitable instruments are,
for instance, the EuroQoL 5D, the Health Utility Index and
the Short Form 6D. Disease-specific instruments such as
FertiQoL may be used to provide additional relevant dis-
ease-specific information.
Note that using cost-utility studies to determine the
value for money of treating fertility problems is not with-
out dispute. Fertility treatments may be argued to be one
of the very few parts of health care not primarily aimed at
increasing or maintaining people’s health or welfare. For
instance, the value of creating new life may be difficult to
grasp in our current economic evaluations, as the future
QALYs gained (and the economic value) of the baby born
as a result of fertility treatment are commonly not included
in cost-effectiveness studies. Another challenging factor is
that parenthood (the result of successful fertility treatment)
may also have negative effects on quality of life [36]. These
aspects are important to consider in fertility-related quality-
of-life research.
Conclusions
Quality of life and well-being related to having fertility
problems is regularly studied. However, the reported qual-
ity-of-life information is not suitable for use in cost-utility
studies. There is a clear need for studies investigating the
impact of fertility problems on quality of life in a way that
outcomes can be compared across studies and dis-
ease areas.
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